SCHEMBL112926

SCHEMBL112926

O=C(CCN(C(=O)O)c1ccc(OCC(=O)c2ccccc2)cc1)Nc1ccc2cnccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 6/20 0.51
LTA4H P09960 1/20 0.47
IMPDH2 P12268 2/20 0.47
ROCK1 Q13464 1/20 0.46
GALR3 O60755 2/20 0.46
RAB9A P51151 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 1/20 0.45
KMT2A Q03164 1/20 0.45
ROCK2 O75116 2/20 0.45
LMNA P02545 2/20 0.44
STAT3 P40763 1/20 0.44
PRMT3 O60678 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15844181 0.90 NOTUM (0.47) NOTUMLTA4HIMPDH2ROCK1GALR3
SCHEMBL114094 0.84 LTA4H (0.49) NOTUMLTA4HIMPDH2ROCK1ROCK2
SCHEMBL113082 0.82 ROCK2 (0.52) NOTUMIMPDH2ROCK1ROCK2PRMT3
SCHEMBL16056718 0.81 ROCK2 (0.56) NOTUMIMPDH2ROCK1ROCK2PRMT3
SCHEMBL115009 0.81 ROCK2 (0.53) NOTUMIMPDH2ROCK1ROCK2PRMT3
SCHEMBL112509 0.80 NOTUM (0.46) NOTUMIMPDH2ROCK1ROCK2PRMT3
SCHEMBL12202000 0.79 NOTUM (0.76) NOTUMIMPDH2ROCK1GALR3NPC1
SCHEMBL113436 0.76 IMPDH2 (0.47) NOTUMIMPDH2ROCK1ROCK2PRMT3
SCHEMBL2777629 0.75 NOTUM (0.44) NOTUMLTA4HIMPDH2ROCK1ROCK2
SCHEMBL9883133 0.75 ROCK2 (0.77) ROCK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424842-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
EP-2424857-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010127329-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed
WO-2010127330-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHAMACEUTICALS, INC. (US) 2010-11-04 WO disclosed
WO-2010126626-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed